Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2018 |
1,545 |
HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative |
2018 |
229 |
HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative |
2018 |
152 |
HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative |
2018 |
652 |
HTS_TST |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative |
2018 |
435 |
HTS_TST |
Sum of Test Result disaggregates |
2018 |
77 |
HTS_TST_POS |
By Test Result: Positive |
2018 |
77 |
HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive |
2018 |
13 |
HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive |
2018 |
8 |
HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive |
2018 |
35 |
HTS_TST_POS |
Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive |
2018 |
21 |
PP_PREV |
Age/sex: 10-14 Female |
2018 |
2,194 |
PP_PREV |
Age/sex: 10-14 Male |
2018 |
1,099 |
PP_PREV |
Age/sex: 15-19 Female |
2018 |
7,679 |
PP_PREV |
Age/sex: 15-19 Male |
2018 |
4,390 |
PP_PREV |
Age/sex: 20-24 Female |
2018 |
8,778 |
PP_PREV |
Age/sex: 20-24 Male |
2018 |
6,583 |
PP_PREV |
Age/sex: 25-49 Female |
2018 |
6,583 |
PP_PREV |
Age/sex: 25-49 Male |
2018 |
6,579 |
PP_PREV |
Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period |
2018 |
45,234 |
PP_PREV |
Sum of Age/Sex disaggregates |
2018 |
43,885 |
PrEP_NEW |
Female 15-19 |
2018 |
5 |
PrEP_NEW |
Female 20-24 |
2018 |
18 |
PrEP_NEW |
Female 25-49 |
2018 |
31 |
PrEP_NEW |
Female 50+ |
2018 |
6 |
PrEP_NEW |
Male 15-19 |
2018 |
3 |
PrEP_NEW |
Male 20-24 |
2018 |
12 |
PrEP_NEW |
Male 25-49 |
2018 |
21 |
PrEP_NEW |
Male 50+ |
2018 |
4 |
PrEP_NEW |
Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection |
2018 |
100 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Female |
2018 |
77 |
TX_NEW |
Aggregated Grouping by Age/Sex: <15 Male |
2018 |
52 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2018 |
223 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2018 |
148 |
TX_NEW |
Breastfeeding status |
2018 |
1 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2018 |
500 |
TX_NEW |
Pregnancy status |
2018 |
3 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2018 |
500 |